MGO One Seven’s Cardiol Therapeutics CRDL Stock Holding History

MGO One Seven’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Hold	100,000	–	–	﹤0.01%	1513
2026 Q1	$135K	Hold	100,000	–	–	﹤0.01%	1367
2025 Q4	$95.4K	Hold	100,000	–	–	﹤0.01%	1369
2025 Q3	$107K	Hold	100,000	–	–	﹤0.01%	1293
2025 Q2	$136K	Hold	100,000	–	–	﹤0.01%	1162
2025 Q1	$97K	Hold	100,000	–	–	﹤0.01%	1065
2024 Q4	$128K	Hold	100,000	–	–	﹤0.01%	1035
2024 Q3	$198K	Hold	100,000	–	–	0.01%	941
2024 Q2	$202K	Hold	100,000	–	–	0.01%	909
2024 Q1	$181K	Hold	100,000	–	–	0.01%	853
2023 Q4	$84.3K	Hold	100,000	–	–	﹤0.01%	877
2023 Q3	$89.5K	Hold	100,000	–	–	0.01%	804
2023 Q2	$89K	Buy	+100,000	New	+$66K	0.01%	764
2022 Q4	–	Sell	-10,000	Closed	-$10K	–	748
2022 Q3	$10K	Hold	10,000	–	–	﹤0.01%	712
2022 Q2	$13K	Buy	+10,000	New	+$14.2K	﹤0.01%	639

Other funds holding CRDL

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MGO One Seven's CRDL Position: Q2 2026 in Review

MGO One Seven held its Cardiol Therapeutics (CRDL) position steady in Q2 2026 at 100,000 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

MGO One Seven first reported a position in CRDL in Q2 2022 and has held it in 15 quarters since. The position peaked at $202K in Q2 2024. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

MGO One Seven held 100,000 shares of Cardiol Therapeutics worth $106K as of Q2 2026.
MGO One Seven left its Cardiol Therapeutics share count unchanged in Q2 2026.
Cardiol Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1513 holding.
MGO One Seven first reported a position in Cardiol Therapeutics in Q2 2022 and has held it in 15 quarters since.
MGO One Seven's Cardiol Therapeutics position peaked at $202K in Q2 2024.
52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.